Interaction of ApoA-IV with NR4A1 and NR1D1 Represses G6Pase and PEPCK Transcription: Nuclear Receptor-Mediated Downregulation of Hepatic Gluconeogenesis in Mice and a Human Hepatocyte Cell Line-Reference-Cited by-同舟云学术

Interaction of ApoA-IV with NR4A1 and NR1D1 Represses G6Pase and PEPCK Transcription: Nuclear Receptor-Mediated Downregulation of Hepatic Gluconeogenesis in Mice and a Human Hepatocyte Cell Line

Published:2015-11-10 Issue:11 Volume:10 Page:e0142098
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Li Xiaoming,Xu Min,Wang Fei,Ji Yong,DavidsoN W. Sean,Li Zongfang,Tso Patrick

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells;LF Lau;EMBO J,1985

2. Mechanical agitation induces gene expression of NOR-1 and its closely related orphan nuclear receptors in leukemic cell lines;S Bandoh;Leukemia,1997

3. Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise;DJ Mahoney;FASEB J,2005

4. Expression of NOR-1 and its closely related members of the steroid/thyroid hormone receptor superfamily in human neuroblastoma cell lines;K Maruyama;Cancer Lett,1995

5. Nuclear receptors Nor1 and NGFI-B/Nur77 play similar, albeit distinct, roles in the hypothalamo-pituitary-adrenal axis;PM Fernandez;Endocrinology,2000

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apolipoprotein A-IV and its derived peptide, T55−121, improve glycemic control and increase energy expenditure;Life Metabolism;2024-03-14

2. Recent Advances in Hepatic Metabolic Regulation by the Nuclear Factor Rev-erbɑ;Current Drug Metabolism;2024-01

3. Targeting NR1D1 in organ injury: challenges and prospects;Military Medical Research;2023-12-11

4. Deficiency of apoA-IV in Female 129X1/SvJ Mice Leads to Diet-Induced Obesity, Insulin Resistance, and Decreased Energy Expenditure;Nutrients;2023-11-02

5. Advances in the pharmacological effects and molecular mechanisms of emodin in the treatment of metabolic diseases;Frontiers in Pharmacology;2023-10-31